Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Link to article at PubMed

Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Cochrane Database Syst Rev. 2011;1:CD006682

Authors: Plummer A, Wildman M

Respiratory disease is the major cause of mortality and morbidity in cystic fibrosis (CF). Life expectancy of people with CF has increased dramatically in the last 40 years. One of the major reasons for this increase is the mounting use of antibiotics to treat chest exacerbations caused by bacterial infections. The optimal duration of intravenous antibiotic therapy is not clearly defined. Individuals usually receive intravenous antibiotics for 14 days, but treatment may range from 10 to 21 days. A shorter duration of antibiotic treatment risks inadequate clearance of infection which could lead to further lung damage. Prolonged courses of intravenous antibiotics are expensive and inconvenient and the incidence of allergic reactions to antibiotics also increases with prolonged courses. The use of aminoglycosides requires frequent monitoring to avoid some of their side effects. However, some organisms which infect people with CF are known to be multi-resistant to antibiotics, and may require a longer course of treatment.

PMID: 21249681 [PubMed - in process]

Leave a Reply

Your email address will not be published.